Adri Gm van der Zanden
Research Subjects
Research Interests
Adri Gm van der Zanden has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adriaan Camille Fluit
Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands
1 shared publication - Anneke van der Zee
Molecular Diagnostics Unit, Maasstad Hospital, Rotterdam, The Netherlands
1 shared publication - Gerda Bosman
Maasstad Laboratory, Molecular Diagnostics Unit, Maasstad Hospital, Rotterdam, The Netherlands
1 shared publication - Jacobus M Ossewaarde
Maasstad Laboratory, Molecular Diagnostics Unit, Maasstad Hospital, Rotterdam, The Netherlands
1 shared publication - James Cohen Stuart
Medical Centre Alkmaar, Alkmaar, The Netherlands
1 shared publication - Lesla Es Bruijnesteijn van Coppenraet
Laboratory for Medical Microbiology and Infectious Diseases, Isala, Zwolle, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 14 January 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 27
Multi-centre evaluation of real-time multiplex PCR for detection of carbapenemase genes OXA-48, VIM, IMP, NDM and KPC
Resistance to carbapenem antibiotics is emerging worldwide among Enterobacteriaceae. To prevent hospital transmission due to unnoticed carriage of carbapenemase producing micro-organisms in newly admitted patients, or follow-up of patients in an outbreak setting, a molecular screening method was developed for detection of the most prevalent carbapenemase genes; blaOXA-48, blaVIM, blaIMP, blaNDM and blaKPC.
- 14 January 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 27
Open AccessMulti-centre evaluation of real-time multiplex PCR for detection of carbapenemase genes OXA-48, VIM, IMP, NDM and KPC
Resistance to carbapenem antibiotics is emerging worldwide among Enterobacteriaceae. To prevent hospital transmission due to unnoticed carriage of carbapenemase producing micro-organisms in newly admitted patients, or follow-up of patients in an outbreak setting, a molecular screening method was developed for detection of the most prevalent carbapenemase genes; blaOXA-48, blaVIM, blaIMP, blaNDM and blaKPC.